HXBM.US Helix BioMedix Inc

Healthcare Biotechnology USA Stocks
3.29 USD
Close of Nov 4, 2026
1.00 6.50
Market cap
USD 739K
P/E
-
P/B
4.32x
ROE
-35.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is HXBM.US undervalued?

Graham number

The Graham number of Helix BioMedix Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Helix BioMedix Inc fundamental analysis

No fundamental analysis for Helix BioMedix Inc yet.

Helix BioMedix Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Helix BioMedix Inc

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.

Full company profile